SINOGENE
About:
SINOGENE creates an animal gene editing and somatic cell cloning technology platform.
Website: http://sinogene.com.cn/
Top Investors: Lotus Lake Ventures, Shunqi Touzi, Xinuo Hengtong, Jianchuang Zhongmin Chuangtou
Description:
Sinogene uses a solution called somatic cell nuclear transfer for pet cloning. Sinogene believes that the advancement of breeding and genetics will be beneficial to animal genetic research. The company's team includes scientists, doctors, and veterinary specialists.
Total Funding Amount:
80M CNY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Changping, Beijing, China
Founded Date:
2012-11-14
Contact Email:
clone(AT)sinogene.com.cn
Founders:
Number of Employees:
11-50
Last Funding Date:
2020-06-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai